35% to 50% of this excess mortality seems to result from cardiovascular disease (5) . Despite this finding, LGE is a marker of adverse prognosis in many patient populations, including those with cardiomyopathy (8), valvular disease (9), coronary artery disease, and congenital heart disease (10). However, the presence of LGE correlates histologically with replacement fibrosis; it commonly occurs late in the disease process and is believed to be irreversible. Prasad has received honoraria for talks from Bayer. Dr. Vassiliou has reported that he has no relationships relevant to the contents of this paper to disclose. E-mail: s.prasad@rbht.nhs.uk.
